Search Results 371-380 of 17464 for protein distribution
... Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma.
Genetically manipulating protein level in colon cancer cells can improve effectiveness of chemotherapy, Mayo Clinic. Cancer. Genetically manipulating protein ...
ROCHESTER, Minn. — Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a Parkinson's-related protein, ...
Identifying protein that may predict response to PD-1 immunotherapy for melanoma. Joe Dangor. September 16, 2015. First · Previous ... 320 · 321 · 322 · 323 ...
Marla Broadfoot, Ph.D. October 14, 2025. Mayo Clinic researchers discover 'traffic controller' protein that protects ...
Mayo Clinic researchers and collaborators zeroed in on the mechanism by which different forms of a protein associated with frontotemporal dementia could affect ...
Protein may Predict Response to Immunotherapy in Patients with Metastatic Melanoma. Joe Dangor. May 5, 2016. Research Suggests Diabetes Drug Acts ...
Protein may Predict Response to Immunotherapy in Patients with Metastatic Melanoma featured image. Cancer. Protein may Predict Response to Immunotherapy in ...
Nanomedicine and drug delivery. We engineer lipid-based and polymer-based nanoparticles for targeted delivery of chemotherapy, gene therapy and cancer vaccines.
Mayo Clinic researchers discover 'traffic controller' protein that protects DNA, and may help kill cancer cells. Alison Satake. October 8, 2025. AI Summit ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!